Actinium Pharmaceuticals, Inc. (ATNM) announced that two patent applications related to its Actimab-a and Iomab-Act projects have been granted by the Canadian Intellectual Property Office.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
The approval of these two patents further consolidates the company's intellectual property position in the field of targeted radiotherapy, providing a stronger legal guarantee for the commercialization prospects of its core candidate drugs.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Lagarde reiterates she will leave the European Central Bank in 2027 but refuses to provide an exact date
Christine Lagarde reiterated that she will step down as President of the European Central Bank in 2027 but refused to say whether she will remain in office until her term ends in October next year.
智通财经•2026/09/18 11:21
Dillard's to Transfer Primary Listings From NYSE to Texas Stock Exchange
MT newswire•2026/09/18 11:21
Roivant Sciences holds annual shareholder meeting
Bitget•2026/09/18 11:15
Crypto prices
More
Bitcoin
BTC
$78,059.26
+2.28%
Ethereum
ETH
$2,501.73
+2.75%
Tether USDt
USDT
$0.9991
+0.00%
BNB
BNB
$749.47
+3.74%
XRP
XRP
$1.32
+1.90%
USDC
USDC
$0.9999
-0.01%
Solana
SOL
$105.53
+5.51%
TRON
TRX
$0.3373
+0.89%
Zcash
ZEC
$1,466.08
+8.55%
Hyperliquid
HYPE
$89.85
+12.74%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now